AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34567787 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks centre-based CR followed by 12 weeks mHealth home-based CR
Number of subjects: 132
Study 34567787 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks combined centre-based+mHealth home-based CR followed by 12 weeks mHealth home-based CR
Number of subjects: 132
Study 34567787 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks centre-based CR (standard care)
Number of subjects: 132
Study 34058256 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct care in Spanish by bilingual physicians
Number of subjects: 83
Study 34058256 — intervention group
Group type: COMPARATOR
Intervention: Care through professional interpretive services
Number of subjects: 83
Study 32081240 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency renal denervation
Number of subjects: 51
Study 32081240 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 51
Study 34665453 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol (MI) 4 g/day
Number of subjects: 66
Study 34665453 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET) 1500 mg/day
Number of subjects: 66
Study 34665453 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MET and MI
Number of subjects: 66
Study 34190055 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (VitD) supplementation
Number of subjects: 161
Study 34190055 — intervention group
Group type: COMPARATOR
Intervention: Wnt16 gKO mice with high dosage VitD diet
Number of subjects: 161
Study 34190055 — intervention group
Group type: COMPARATOR
Intervention: AIS subjects
Number of subjects: 161
Study 33333492 — intervention group
Group type: EXPERIMENTAL
Intervention: Fun For Wellness (FFW) intervention (nFFW = 331)
Number of subjects: 667
Study 33333492 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 667
Study 35055558 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal low-frequency stimulation (PLS) group (n = 20)
Number of subjects: 39
Study 35055558 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy group (PTG) (n = 19)
Number of subjects: 39
Study 32562433 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness representation-focused patient education during hospitalization and telephone follow-ups after discharge
Number of subjects: 107
Study 32562433 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 107
Study 33478442 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents living with perinatal HIV (ALPHIV)
Number of subjects: 707
Study 33478442 — intervention group
Group type: COMPARATOR
Intervention: HIV-uninfected adolescents (controls)
Number of subjects: 707
Study 36336757 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (2 mA, 30 min, 22 sessions)
Number of subjects: 49
Study 36336757 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram 20 mg/day
Number of subjects: 49
Study 36336757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 34626918 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet (ED) - Elental® 160 g/day
Number of subjects: 117
Study 34626918 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (Control group)
Number of subjects: 117
Study 32862174 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 160
Study 32862174 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 160
Study 35260152 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle-modification program (10-week-day clinic program)
Number of subjects: 47
Study 33258297 — intervention group
Group type: EXPERIMENTAL
Intervention: Fused Deposition Modeling (FDM)
Number of subjects: 20
Study 33258297 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Light Processing (DLP)
Number of subjects: 20
Study 34808104 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practice alerts (BPA)
Number of subjects: 1310
Study 34808104 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1310
Study 34768696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical lateral glide (CLG)
Number of subjects: 72
Study 34768696 — intervention group
Group type: COMPARATOR
Intervention: Cervical lateral glide + median nerve neural mobilization (CLG + MNNM)
Number of subjects: 72
Study 36089597 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine patches
Number of subjects: 0
Study 36089597 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 0
Study 33737034 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02% ophthalmic solution
Number of subjects: 29
Study 33737034 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 29
Study 33081739 — intervention group
Group type: EXPERIMENTAL
Intervention: Sankofa pediatric HIV disclosure intervention
Number of subjects: 157
Study 36017827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-day rivastigmine transdermal patch (RID-TDS)
Number of subjects: 57
Study 36017827 — intervention group
Group type: COMPARATOR
Intervention: Exelon® transdermal patch
Number of subjects: 57
Study 34541475 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei Shirota (LcS)
Number of subjects: 359
Study 34541475 — intervention group
Group type: COMPARATOR
Intervention: Proton pump inhibitors (PPI)
Number of subjects: 359
Study 36309727 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2.5 grams per day)
Number of subjects: 70
Study 36309727 — intervention group
Group type: COMPARATOR
Intervention: Sunflower-seed oil (placebo)
Number of subjects: 70
Study 32855054 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (40 mcg)
Number of subjects: 80
Study 32855054 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (20 mg)
Number of subjects: 80
Study 34806396 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) - 1 fraction of 15-24 Gy or 3 fractions of 8 Gy
Number of subjects: 20
Study 34806396 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT)
Number of subjects: 20
Study 34806396 — intervention group
Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT) - 20 Gy in 5 fractions
Number of subjects: 20
Study 33317461 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbidol (ARB)
Number of subjects: 100
Study 33317461 — intervention group
Group type: COMPARATOR
Intervention: KALETRA (Lopinavir/ritonavir)
Number of subjects: 100
Study 36081295 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (2 g/day)
Number of subjects: 207
Study 36081295 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g/day)
Number of subjects: 207
Study 36081295 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation
Number of subjects: 207
Study 33448755 — intervention group
Group type: COMPARATOR
Intervention: Sham KT and mCIMT group
Number of subjects: 35
Study 33448755 — intervention group
Group type: EXPERIMENTAL
Intervention: KT group
Number of subjects: 35
Study 33448755 — intervention group
Group type: EXPERIMENTAL
Intervention: KT and mCIMT group
Number of subjects: 35
Study 34669956 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine e‐cigarettes (2.4% nicotine, n = 118)
Number of subjects: 234
Study 34669956 — intervention group
Group type: COMPARATOR
Intervention: No-nicotine e‐cigarettes (n = 116)
Number of subjects: 234
Study 36858762 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-delivered cognitive behavioral therapy (CBT-txt) with 197 text messages over 4 weeks (average 12 texts every other day)
Number of subjects: 102
Study 36858762 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 102
Study 36858762 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-delivered cognitive behavioral therapy (CBT-txt)
Number of subjects: 102
Study 34344851 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid bacteria‐containing beverage
Number of subjects: 40
Study 34344851 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 40
Study 33568079 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 0
Study 33568079 — intervention group
Group type: COMPARATOR
Intervention: Comparator (not using telemonitoring)
Number of subjects: 0
Study 32493442 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 42
Study 32493442 — intervention group
Group type: COMPARATOR
Intervention: Sham transplantation
Number of subjects: 42
Study 34415866 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care augmented by the display of a sepsis early warning system-triggered flag and electronic health record-based pharmacist notification
Number of subjects: 598
Study 34415866 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 598
Study 33805975 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel organic olive oil-based denture adhesive
Number of subjects: 23
Study 33805975 — intervention group
Group type: COMPARATOR
Intervention: Commercialized adhesive (control)
Number of subjects: 23
Study 33805975 — intervention group
Group type: COMPARATOR
Intervention: Vaseline (placebo)
Number of subjects: 23
Study 32007295 — intervention group
Group type: EXPERIMENTAL
Intervention: U-TURN group (intensive lifestyle intervention with supervised exercise and individualized dietary counseling)
Number of subjects: 92
Study 32007295 — intervention group
Group type: EXPERIMENTAL
Intervention: U-TURN group (intermediate tertile)
Number of subjects: 92
Study 32007295 — intervention group
Group type: EXPERIMENTAL
Intervention: U-TURN group (upper tertile)
Number of subjects: 92
Study 32007295 — intervention group
Group type: EXPERIMENTAL
Intervention: U-TURN group (lower tertile)
Number of subjects: 92
Study 32007295 — intervention group
Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 92
Study 34746999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Vitamin C (2 g every 6 hours for 5 days)
Number of subjects: 54
Study 34746999 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 54
Study 34774076 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended educational intervention program
Number of subjects: 84
Study 34774076 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 84
Study 32816629 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic distal gastrectomy
Number of subjects: 1050
Study 32816629 — intervention group
Group type: COMPARATOR
Intervention: Open distal gastrectomy
Number of subjects: 1050
Study 35839921 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic treadmill rehabilitation (TM; 3 times/wk for 6 months)
Number of subjects: 246
Study 35839921 — intervention group
Group type: COMPARATOR
Intervention: Stretching/balance (ST; 2 times/wk for 6 months)
Number of subjects: 246
Study 33497834 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed appendectomy (after 6 am)
Number of subjects: 0
Study 33497834 — intervention group
Group type: COMPARATOR
Intervention: Early appendectomy (within 6 hours of randomization)
Number of subjects: 0
Study 33175057 — intervention group
Group type: EXPERIMENTAL
Intervention: FunFRIENDS program (Intervention Group, N = 21)
Number of subjects: 43
Study 33175057 — intervention group
Group type: COMPARATOR
Intervention: Control Group (N = 22)
Number of subjects: 43
Study 36351512 — intervention group
Group type: EXPERIMENTAL
Intervention: Home meal delivery and provision of cooking/serving resources (MOW cohort, n=83)
Number of subjects: 299
Study 36351512 — intervention group
Group type: EXPERIMENTAL
Intervention: Home meal delivery and provision of cooking/serving resources (COM cohort, n=216)
Number of subjects: 299
Study 36351512 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 299
Study 34166466 — intervention group
Group type: EXPERIMENTAL
Intervention: Burnout prevalence
Number of subjects: 229
Study 34166466 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhaustion
Number of subjects: 229
Study 34166466 — intervention group
Group type: EXPERIMENTAL
Intervention: Disengagement
Number of subjects: 229
Study 34166466 — intervention group
Group type: EXPERIMENTAL
Intervention: Neither exhausted nor disengaged
Number of subjects: 229
Study 34166466 — intervention group
Group type: COMPARATOR
Intervention: Association with age, gender, and year of study
Number of subjects: 229
Study 33539744 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-based doublet plus bevacizumab (10 mg/kg intravenous every 14 days or 15 mg/kg every 21 days)
Number of subjects: 406
Study 33539744 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-based doublet alone (standard chemotherapy)
Number of subjects: 406
Study 33539744 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-based doublet plus bevacizumab
Number of subjects: 406
Study 33539744 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 406
Study 33009665 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab
Number of subjects: 1890
Study 33009665 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab
Number of subjects: 1890
Study 33009665 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly and Monthly fremanezumab
Number of subjects: 1890
Study 32108723 — intervention group
Group type: EXPERIMENTAL
Intervention: Hardwood surface
Number of subjects: 38
Study 32108723 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pellet turf
Number of subjects: 38
Study 32108723 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass surface
Number of subjects: 38
Study 32108723 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial turf
Number of subjects: 38
Study 32108723 — intervention group
Group type: COMPARATOR
Intervention: Concrete surface
Number of subjects: 38
Study 33985942 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 200 mg every 4 weeks (Q4W)
Number of subjects: 391
Study 33985942 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 20 mg Q12W (switched to 200 mg at W24)
Number of subjects: 391
Study 33985942 — intervention group
Group type: COMPARATOR
Intervention: Placebo Q4W
Number of subjects: 391
Study 33985942 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 391
Study 34595963 — intervention group
Group type: EXPERIMENTAL
Intervention: Free From Falls (FFF) group education and exercise program (eight weekly 2 hour sessions)
Number of subjects: 96
Study 34595963 — intervention group
Group type: COMPARATOR
Intervention: Control condition (a fall prevention brochure and informing their neurologist of their fall history)
Number of subjects: 96
Study 32972484 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based nutrition education by trained health volunteers focused on types of locally produced foods and appropriate preparation methods.
Number of subjects: 84
Study 32972484 — intervention group
Group type: EXPERIMENTAL
Intervention: Construction of dams at the community level to facilitate all year round farming including rearing of animals.
Number of subjects: 84
Study 32972484 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of agricultural materials such as high yield seedlings, pesticides, and fertiliser.
Number of subjects: 84
Study 32658647 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35737996 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed educational posters promoting sexual consent
Number of subjects: 40
Study 35737996 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed educational posters promoting sexual consent (for males)
Number of subjects: 40
Study 34376319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) into the MTrP area (10 needle insertions)
Number of subjects: 50
Study 34376319 — intervention group
Group type: COMPARATOR
Intervention: Control group (Dry Needling into the taut band (TB) area)
Number of subjects: 50
Study 35451678 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg zinc gluconate daily)
Number of subjects: 98
Study 35451678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 35382377 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led education + booklet
Number of subjects: 56
Study 35382377 — intervention group
Group type: COMPARATOR
Intervention: Booklet only (control group)
Number of subjects: 56
Study 33519434 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanxinshutong (GXST) capsules
Number of subjects: 480
Study 33519434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 34563627 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose electro-acupuncture (EA) - seven times each chemotherapy cycle for three cycles
Number of subjects: 66
Study 34563627 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose electro-acupuncture (EA) - three times each chemotherapy cycle
Number of subjects: 66
Study 34563627 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 66
Study 34563627 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose electro-acupuncture (EA)
Number of subjects: 66
Study 32950920 — intervention group
Group type: EXPERIMENTAL
Intervention: Small marker (9.5 mm, 1 g)
Number of subjects: 17
Study 32950920 — intervention group
Group type: COMPARATOR
Intervention: Large marker (14 mm, 2 g)
Number of subjects: 17
Study 35875916 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2 μg/kg
Number of subjects: 120
Study 35875916 — intervention group
Group type: COMPARATOR
Intervention: Oral melatonin 0.5 mg kg ‐1
Number of subjects: 120
Study 33508735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance (CO-OP) with additional parental coaching
Number of subjects: 22
Study 33508735 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Orientation to daily Occupational Performance (CO-OP) without additional parental coaching (active control)
Number of subjects: 22
Study 35766954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (ILI) 1.5 mg/kg as a bolus followed by 1.5 mg/kg/h until the end of surgery (Group L)
Number of subjects: 43
Study 35766954 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group NL)
Number of subjects: 43
Study 35005205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (60 min/session, twice/week for 24 weeks)
Number of subjects: 107
Study 35005205 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 107
Study 35005205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 107
Study 35005205 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study 36448328 — intervention group
Group type: EXPERIMENTAL
Intervention: Napping 15-59 minutes
Number of subjects: 116
Study 36448328 — intervention group
Group type: EXPERIMENTAL
Intervention: Napping 60+ minutes
Number of subjects: 116
Study 36448328 — intervention group
Group type: EXPERIMENTAL
Intervention: Napping overall
Number of subjects: 116
Study 36448328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime sleep parameters
Number of subjects: 116
Study 33653204 — intervention group
Group type: EXPERIMENTAL
Intervention: Gameplay (B)
Number of subjects: 42
Study 33653204 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined didactic module followed by gameplay (D)
Number of subjects: 42
Study 33653204 — intervention group
Group type: COMPARATOR
Intervention: Didactic module (C)
Number of subjects: 42
Study 33653204 — intervention group
Group type: COMPARATOR
Intervention: Control (A)
Number of subjects: 42
Study 33038262 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus 12-week intervention (weekly choir rehearsal and daily breathing exercises)
Number of subjects: 24
Study 33038262 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 24
Study 35443733 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at Laogong acupoint interval with Panax notoginseng
Number of subjects: 74
Study 35443733 — intervention group
Group type: COMPARATOR
Intervention: Control group (handgrip exercise)
Number of subjects: 74
Study 35584197 — intervention group
Group type: EXPERIMENTAL
Intervention: AKL-T01 (tablet-based digital treatment)
Number of subjects: 60
Study 35584197 — intervention group
Group type: COMPARATOR
Intervention: No contact control
Number of subjects: 60
Study 34298114 — intervention group
Group type: COMPARATOR
Intervention: Composite (CO)
Number of subjects: 180
Study 34298114 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass hybrid (GH)
Number of subjects: 180
Study 34165095 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding for 5-10 minutes before immunization
Number of subjects: 124
Study 34165095 — intervention group
Group type: COMPARATOR
Intervention: Control group (no breastfeeding)
Number of subjects: 124
Study 35475684 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 60 billion CFU daily for 4 weeks
Number of subjects: 81
Study 35475684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 35475684 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 81
Study 35475684 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) and Placebo
Number of subjects: 81
Study 34878549 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt substitute (free salt substitute provided)
Number of subjects: 1170
Study 34878549 — intervention group
Group type: COMPARATOR
Intervention: Regular salt (control group)
Number of subjects: 1170
Study 35443143 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-back n-back WM training
Number of subjects: 0
Study 35443143 — intervention group
Group type: COMPARATOR
Intervention: 0, 1, 2-back n-back WM training
Number of subjects: 0
Study 35443143 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous attended sensory input
Number of subjects: 0
Study 35443143 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved WM capacity
Number of subjects: 0
Study 34155070 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided daily multidisciplinary rounds (DMRs) supported by a remote specialist and audit/feedback on care performance
Number of subjects: 30
Study 32615109 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 45